Stolz & Associates PS Purchases New Stake in Agilent Technologies, Inc. $A

Stolz & Associates PS purchased a new stake in Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 3,277 shares of the medical research company’s stock, valued at approximately $565,000. Agilent Technologies makes up approximately 0.3% of Stolz & Associates PS’s portfolio, making the stock its 21st largest position.

Other institutional investors also recently modified their holdings of the company. 71 West Capital Partners lifted its holdings in shares of Agilent Technologies by 14.5% during the third quarter. 71 West Capital Partners now owns 3,311 shares of the medical research company’s stock valued at $571,000 after purchasing an additional 420 shares during the last quarter. Kestra Investment Management LLC boosted its position in shares of Agilent Technologies by 4.9% in the 3rd quarter. Kestra Investment Management LLC now owns 11,702 shares of the medical research company’s stock valued at $2,016,000 after purchasing an additional 547 shares during the period. AlphaCore Capital LLC boosted its position in shares of Agilent Technologies by 43.9% in the 3rd quarter. AlphaCore Capital LLC now owns 7,713 shares of the medical research company’s stock valued at $1,329,000 after purchasing an additional 2,353 shares during the period. Fulcrum Asset Management LLP acquired a new position in shares of Agilent Technologies in the 3rd quarter valued at $4,881,000. Finally, Allspring Global Investments Holdings LLC increased its stake in Agilent Technologies by 0.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 220,403 shares of the medical research company’s stock worth $36,737,000 after purchasing an additional 1,255 shares in the last quarter.

Agilent Technologies Price Performance

A opened at $178.02 on Wednesday. The stock has a fifty day moving average of $166.93 and a 200-day moving average of $137.60. The firm has a market capitalization of $50.19 billion, a P/E ratio of 35.04, a PEG ratio of 2.64 and a beta of 1.24. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $182.99. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same quarter last year, the firm posted $1.37 earnings per share. Agilent Technologies’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 6.20 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were paid a $0.2550 dividend. This represents a $1.02 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is currently 20.08%.

Wall Street Analysts Forecast Growth

A has been the topic of several recent analyst reports. Stifel Nicolaus boosted their price objective on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Evercore raised their target price on shares of Agilent Technologies from $148.00 to $178.00 and gave the stock an “outperform” rating in a report on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Agilent Technologies in a report on Monday, October 26th. They issued a “buy” rating and a $190.00 target price for the company. Finally, Citigroup lifted their target price on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Eighteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $181.45.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. This trade represents a 11.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Agilent Technologies Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.